Zealand Pharma A/S Stock Price Today (NSE: ZEAL)
Fundamental Score
Zealand Pharma A/S Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Zealand Pharma A/S share price today is ₹73.55, down 5.22% on NSE/BSE as of 22 September 2026. Zealand Pharma A/S (ZEAL) is a Small-cap company in the Logistics Solution Provider sector with a market capitalisation of ₹87.31 (Cr). The 52-week high for ZEAL share price is ₹124.75 and the 52-week low is ₹55.90. At a P/E ratio of 7.83x, ZEAL is currently trading below its industry average P/E of 25.01x. The company has a Return on Equity (ROE) of 12.85% and a debt-to-equity ratio of 0.22.
Zealand Pharma A/S Share Price Chart — NSE/BSE Historical Performance
Zealand Pharma A/S share price chart: 42.70% return over the past month. 52-week high ₹124.75, 52-week low ₹55.90.
Zealand Pharma A/S — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹78.20 | ₹78.20 | ₹73.20 | ₹73.55 | 3.00K (Cr) | |
| ₹75.50 | ₹78.00 | ₹75.50 | ₹77.60 | 6.00K (Cr) | |
| ₹75.30 | ₹82.50 | ₹75.30 | ₹80.00 | 7.20K (Cr) | |
| ₹75.00 | ₹75.00 | ₹75.00 | ₹75.00 | 600.00 (Cr) | |
| ₹80.00 | ₹80.00 | ₹75.20 | ₹77.50 | 3.60K (Cr) | |
| ₹77.00 | ₹83.50 | ₹77.00 | ₹83.50 | 7.20K (Cr) | |
| ₹78.00 | ₹78.00 | ₹74.15 | ₹76.55 | 1.80K (Cr) | |
| ₹87.30 | ₹87.50 | ₹80.55 | ₹80.55 | 6.00K (Cr) | |
| ₹91.00 | ₹91.00 | ₹85.00 | ₹87.10 | 6.00K (Cr) | |
| ₹85.00 | ₹93.55 | ₹85.00 | ₹91.40 | 39.00K (Cr) |
Zealand Pharma A/S — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹62.50 | ₹93.55 | ₹61.50 | ₹73.55 | +17.68% | |
| ₹63.50 | ₹66.45 | ₹60.60 | ₹62.50 | -1.57% | |
| ₹65.00 | ₹68.65 | ₹63.60 | ₹65.60 | +0.92% | |
| ₹71.10 | ₹71.10 | ₹65.00 | ₹68.00 | -4.36% | |
| ₹70.90 | ₹72.45 | ₹62.10 | ₹70.90 | +0.00% | |
| ₹59.95 | ₹97.00 | ₹59.95 | ₹70.90 | +18.27% | |
| ₹70.80 | ₹77.00 | ₹55.90 | ₹57.30 | -19.07% | |
| ₹71.50 | ₹90.40 | ₹71.25 | ₹79.50 | +11.19% | |
| ₹90.05 | ₹95.00 | ₹72.00 | ₹72.00 | -20.04% | |
| ₹100.05 | ₹101.80 | ₹91.50 | ₹94.00 | -6.05% | |
| ₹108.00 | ₹121.40 | ₹99.15 | ₹102.95 | -4.68% | |
| ₹116.45 | ₹120.90 | ₹101.00 | ₹106.95 | -8.16% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Zealand Pharma A/S Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Zealand Pharma A/S Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ZEAL across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Excellent ROCE Performance (16.57%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 7.83 vs Industry: 25.01)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (21.15%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (36.35% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (43.69% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.22)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.23x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (73.40%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Revenue Contraction (-42.16%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-22.69% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-14.20 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 2.44%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Zealand Pharma A/S vs Logistics Solution Provider Peers
Peer Comparison - Logistics Solution Provider
Compare Zealand Pharma A/S with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
55.8/100 | ₹73.55₹74 | ₹87.31₹87.31 | 7.83Average 7.8 Average | 12.85%Average 12.85% Average | 16.57%Good 16.57% Good | 0.22Excellent 0.2 Excellent | 43.69%Excellent 43.69% Excellent | 36.35%Excellent 36.35% Excellent | 0.00% | |
Container Corporation of India LimitedContainer Corpo... CONCOR • 531344 | 45.5/100 | ₹510.30₹510 | ₹38865.47₹38865.47 | 31.15Average 31.2 Average | 9.81%Poor 9.81% Poor | 12.46%Average 12.46% Average | 0.00Excellent 0.0 Excellent | 19.71%Excellent 19.71% Excellent | 7.15%Good 7.15% Good | 1.87% |
Delhivery LimitedDelhivery Limit... DELHIVERY • 543529 | 32.6/100 | ₹450.30₹450 | ₹33720.72₹33720.72 | 360.24Average 360.2 Average | 1.60%Poor 1.60% Poor | 2.58%Poor 2.58% Poor | 0.00Excellent 0.0 Excellent | 19.76%Excellent 19.76% Excellent | 23.57%Excellent 23.57% Excellent | 0.00% |
Blue Dart Express LimitedBlue Dart Expre... BLUEDART • 526612 | 48.8/100 | ₹4925.80₹4926 | ₹11688.92₹11688.92 | 40.72Average 40.7 Average | 0.00%Poor 0.00% Poor | 17.25%Good 17.25% Good | 0.11Excellent 0.1 Excellent | 19.34%Excellent 19.34% Excellent | 13.31%Good 13.31% Good | 0.51% |
63.1/100 | ₹869.05₹869 | ₹6691.69₹6691.69 | 14.60Average 14.6 Average | 19.48%Good 19.48% Good | 16.53%Good 16.53% Good | 0.09Excellent 0.1 Excellent | 25.60%Excellent 25.60% Excellent | 11.90%Good 11.90% Good | 1.08% | |
TVS Supply Chain Solutions LimitedTVS Supply Chai... TVSSCS • 543965 | 33.8/100 | ₹124.68₹125 | ₹5504.62₹5504.62 | 85.40Average 85.4 Average | 5.96%Poor 5.96% Poor | 10.25%Average 10.25% Average | 0.55Good 0.5 Good | 28.84%Excellent 28.84% Excellent | 9.68%Good 9.68% Good | 0.00% |
VRL Logistics LimitedVRL Logistics L... VRLLOG • 539118 | 51.9/100 | ₹288.85₹289 | ₹5053.14₹5053.14 | 18.92Average 18.9 Average | 21.27%Excellent 21.27% Excellent | 18.83%Good 18.83% Good | 0.40Excellent 0.4 Excellent | 39.35%Excellent 39.35% Excellent | 12.81%Good 12.81% Good | 3.26% |
Afcom Holdings LtdAfcom Holdings ... AFCOM • 544224 | 58.5/100 | ₹1630.15₹1630 | ₹4249.49₹4249.49 | 31.70Average 31.7 Average | 36.01%Excellent 36.01% Excellent | 36.69%Excellent 36.69% Excellent | 0.88Good 0.9 Good | 98.76%Excellent 98.76% Excellent | 111.16%Excellent 111.16% Excellent | 0.00% |
Mahindra Logistics LimitedMahindra Logist... MAHLOG • 540768 | 35.6/100 | ₹402.80₹403 | ₹3996.58₹3996.58 | 107.99Average 108.0 Average | 0.28%Poor 0.28% Poor | 7.48%Poor 7.48% Poor | 0.04Excellent 0.0 Excellent | -40.22%Poor -40.22% Poor | 16.48%Excellent 16.48% Excellent | 0.64% |
Sindhu Trade Links LimitedSindhu Trade Li... SINDHUTRAD • 532029 | 45.8/100 | ₹24.87₹25 | ₹3834.78₹3834.78 | 69.08Average 69.1 Average | 3.42%Poor 3.42% Poor | 2.40%Poor 2.40% Poor | 0.26Excellent 0.3 Excellent | 27.21%Excellent 27.21% Excellent | -10.08%Poor -10.08% Poor | 0.00% |
Gateway Distriparks LimitedGateway Distrip... GATEWAY • 543489 | 48/100 | ₹53.75₹54 | ₹2685.59₹2685.59 | 10.97Average 11.0 Average | 11.37%Average 11.37% Average | 11.08%Average 11.08% Average | 0.13Excellent 0.1 Excellent | 22.07%Excellent 22.07% Excellent | 13.40%Good 13.40% Good | 3.38% |
Top Logistics Solution Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Container Corporation of India Limited share price38865.47 Cr
- Delhivery Limited share price33720.72 Cr
- Blue Dart Express Limited share price11688.92 Cr
- Transport Corporation of India Limited share price6691.69 Cr
- TVS Supply Chain Solutions Limited share price5504.62 Cr
Zealand Pharma A/S PE Ratio History
Historical price-to-earnings ratio for ZEAL — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2023 | ₹7.40 | ₹215.00 | 29x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Zealand Pharma A/S Dividend History
Annual cash dividends paid by ZEAL — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2024 | ₹1.33 Cr |
| FY 2021 | ₹0.02 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Zealand Pharma A/S Quarterly Performance
Latest quarterly metrics for ZEAL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-42.16%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
21.15%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
36.35%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
43.69%
Compounded annual net profit growth over 5 years
Zealand Pharma A/S Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ZEAL — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Zealand Pharma A/S Financial Statements
Annual income statement, balance sheet and cash flow for Zealand Pharma A/S (ZEAL) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Zealand Pharma A/S
About ZEAL (Zealand Pharma A/S)
Zealand Pharma A/S (ZEAL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Logistics Solution Provider sector wi...th a current market capitalisation of ₹87.31 (Cr). Zealand Pharma A/S has delivered a Return on Equity (ROE) of 12.85% and a ROCE of 16.57%. The debt-to-equity ratio stands at 0.22, reflecting the company's capital structure. Investors tracking ZEAL share price can monitor key metrics including P/E ratio, promoter holding of 73.40%, and quarterly earnings growth.
Company Details
ZEAL Share Price: Frequently Asked Questions
What is the current share price of Zealand Pharma A/S?
Zealand Pharma A/S (ZEAL) trades at ₹73.55 on NSE. Market cap ₹87.31 (Cr). Educational data only.
What is the P/E ratio of Zealand Pharma A/S?
Zealand Pharma A/S has a P/E of 7.83x vs industry average 25.01x.
What is the Bull Run score for Zealand Pharma A/S?
Zealand Pharma A/S has a Bull Run score of 55.8/100 based on 25+ financial parameters.
Does Zealand Pharma A/S pay dividends?
Zealand Pharma A/S has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Zealand Pharma A/S?
Zealand Pharma A/S has ROE of 12.85%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Zealand Pharma A/S?
Zealand Pharma A/S has debt-to-equity of 0.22.
Is Zealand Pharma A/S a good investment?
Bull Run gives Zealand Pharma A/S a score of 55.8/100. This is not investment advice — consult a SEBI-registered advisor.